Obesity drugs show promise in combatting substance abuse
GLP-1 receptor agonists, initially for diabetes and weight loss, show promise in substance addiction treatment. A transformative breakthrough in healthcare.
GLP-1 receptor agonists, initially for diabetes and weight loss, show promise in substance addiction treatment. A transformative breakthrough in healthcare.
The South African Border Management Authority has activated its Mpox preparedness plan, implementing robust screening at all ports of entry.
Early results from the PURPOSE 1 trial show that an injectable antiretroviral drug can prevent HIV infection in cisgender women, marking a historic breakthrough.
Seventy percent of foreign-trained doctors failed board exams. Alleging discrepancies, 250 junior doctors seek the release of their scripts from the HPCSA.
Report highlights how climate change causes significant psychological stress in children, emphasising the urgent need for climate-resilient infrastructure.
Investigate the alarming trend of post-pandemic illness and what can be done to strengthen our defenses against common diseases.